CRODEON TECHNOLOGIES
0642.754.761 · rovalta.com · 04/11/2026
CRODEON TECHNOLOGIES
Financial year 2026 · Closed on 31/03/2026
Overview
Identity
Source · BCE/KBOCRODEON TECHNOLOGIES is a Private limited company incorporated in 2015. Its main activity is: Engineering activities and related technical consultancy. Its registered office is in Gent.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0642.754.761
- Incorporation
- 09/11/2015
- Legal form
- Private limited company
- Registered office
- Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map - Contributed capital
- 1 132 500,00 €
- Latest accounts
- 31/03/2026
Joint committees (2)
- 0
- 200
Financials
Source · NBB, 10 filingsTrend over 8 financial years
| 2026 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 317,1 k € | +99.2% | 159,1 k € | +168% | 59,3 k € | +189% | -66,7 k € | -187% | 76,3 k € |
| EBITDA | 115,7 k € | +210% | -105,2 k € | +43.9% | -187,6 k € | +23.5% | -245,3 k € | -316% | -58,9 k € |
| Operating result | -32,1 k € | +82.1% | -178,8 k € | +12.4% | -204,2 k € | +20.8% | -257,7 k € | -289% | -66,3 k € |
| Net result | -135 k € | +36.5% | -212,5 k € | +2.2% | -217,3 k € | +26.6% | -296 k € | -307% | -72,8 k € |
| Balance sheet | |||||||||
| Equity | 204,6 k € | +188% | -233 k € | -1039% | -20,4 k € | -110% | 196,9 k € | +2876% | -7,1 k € |
| Total assets | 895,5 k € | +10.6% | 809,5 k € | +20.5% | 671,8 k € | +62.1% | 414,5 k € | +2.6% | 403,8 k € |
| Cash | 70,4 k € | +435% | 13,2 k € | -49.1% | 25,9 k € | -88.2% | 218,3 k € | +3.1% | 211,8 k € |
| Debts | 582,7 k € | -40.9% | 985,9 k € | +42.6% | 691,3 k € | +218% | 217,6 k € | -47.0% | 410,6 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/03/20263 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/09/2022 | |||
Jonathan Sercu | Directorsince 09/11/2015Bestuurder09/11/2015 → 2023 accountsended | ||
Sam Vanheule | Directorsince 09/11/2015Bestuurder09/11/2015 → 2023 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Bestuurder30/08/2022 → 2023 accounts |
Other companies at this address
Technologiepark-Zwijnaarde 82 9052 Gent| Company | CBE no. |
|---|---|
Amalus Therapeutics● Bankrupt | 0803.929.268 |
APCOR R&M● Active | 0600.952.909 |
Ardoyen● Active | 0875.102.821 |
AVROXA● Active | 0687.774.936 |
Benebiose● Active | 0784.521.548 |
BioNeering● Active | 0807.194.309 |
CONTREL EUROPE● Active | 0426.204.637 |
Cryptobiotix● Active | 0762.565.104 |
Gulliver Biomed● Active | 0692.527.837 |
ImplicitMeasures.com● Bankrupt | 0657.989.701 |
Inbiose● Active | 0534.887.593 |
| 0440.054.752 | |
INNOVATIVE PHARMACEUTICS● Active | 0883.574.582 |
Inspect● Active | 0645.950.417 |
INVIBES ADVERTISING● Active | 0836.533.938 |
KYTOS● Active | 0768.755.286 |
Lares Solutions● Active | 1015.346.906 |
| 0755.350.975 | |
| 0742.910.132 | |
| 0667.765.816 |
Financials
Full financial information
Source · NBB| 2026 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 31/03/2026 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 18 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 11/09/2026 | 06/05/2025 | 30/04/2024 | 03/04/2023 | 14/04/2022 | 11/03/2021 |
| General meeting | 01/09/2026 | 30/03/2025 | 02/04/2024 | 18/03/2023 | 19/03/2022 | 27/02/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/03/2026 | 01/09/2026 | 11/09/2026 | Dutch | |
| Micro modelCorrection | 30/09/2024 | 30/03/2025 | 06/05/2025 | Dutch | |
| Micro model | 30/09/2024 | 30/03/2025 | 30/04/2025 | Dutch | |
| Micro model | 30/09/2023 | 02/04/2024 | 30/04/2024 | Dutch | |
| Micro model | 30/09/2022 | 18/03/2023 | 03/04/2023 | Dutch | |
| Micro model | 30/09/2021 | 19/03/2022 | 14/04/2022 | Dutch | |
| Micro model | 30/09/2020 | 27/02/2021 | 11/03/2021 | Dutch | |
| Abridged model | 30/09/2019 | 15/02/2020 | 18/02/2020 | Dutch | |
| Abridged model | 30/09/2018 | 02/02/2019 | 06/02/2019 | Dutch | |
| Abridged model | 30/09/2017 | 17/03/2018 | 19/03/2018 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/03/20263 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/09/2022 | |||
Jonathan Sercu | Directorsince 09/11/2015Bestuurder09/11/2015 → 2023 accountsended | ||
Sam Vanheule | Directorsince 09/11/2015Bestuurder09/11/2015 → 2023 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Bestuurder30/08/2022 → 2023 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Capital / shares13/04/2026STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Other17/10/2025ALGEMENE VERGADERING - BOEKJAAR
- Mandates09/09/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates24/08/2020STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
- Registered office26/02/2019MAATSCHAPPELIJKE ZETEL
- Registered office05/10/2018MAATSCHAPPELIJKE ZETEL
- Registered office20/09/2016Verplaatsing van de maatschappelijke zetel
- Other12/11/2015Uit een akte verleden voor Meester Michel Van Damme, geassocieerd notaris te Brugge (Sint-
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Technologiepark-Zwijnaarde 82, 9052 ZwijnaardeCurrent | accounts 2021 → 2026 | Accounts 2026 · 2026-00511197 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| CRODEON TECHNOLOGIESCurrent | accounts 2020 → 2026 | Accounts 2026 · 2026-00511197 |
| CRODEON | accounts 2017 → 2019 | Accounts 2019 · 2020-05300196 |
Events
- 2026Annual accounts 2026-135 k €↑
- 2024Annual accounts 2024-212,5 k €↑
- 2023Annual accounts 2023-217,3 k €↑
- 2022Annual accounts 2022-296 k €↓
- 2021Annual accounts 2021-72,8 k €↓
- 2020Name changeCRODEON TECHNOLOGIES
- 2019Annual accounts 201935,9 k €↑
- 2018Annual accounts 20189,8 k €↑
- 2017Annual accounts 2017-8,7 k €
- 09/11/2015IncorporationPrivate limited company